Alan Taylor

Active Investor

Executive Chairperson at Clarity Pharmaceuticals

New South Wales

Alan Taylor, Executive Chairperson at Clarity Pharmaceuticals is an active investor based in New South Wales. This profile covers what Alan Taylor backs, at which stage, and how founders can reach out in 2026.

Dr. Alan Taylor co-founded and served as Chairman at Mizzenit. He has a background as a scientist, investment banker, entrepreneur, and investor. He is currently the Chairman and co-founder of Mizzen Group Pty Ltd, a new technology start-up company in the transport and logistics area. He is also the Executive Chairman at Clarity Pharmaceuticals, a company focused on developing radiopharmaceuticals for the treatment of cancer and other diseases. He is passionate about the commercialization of Australian science and technologies, either in general technology or the life sciences. He has approximately 10 years of investment banking experience and was until recently an Executive Director and shareholder of Inteq Limited, a boutique Australian investment bank, where he remains on the Board of Directors. He has a degree in Applied Finance and Investment from the Financial Services Institute of Australasia, a Bachelor's in Applied Science from the University of Sydney, and a Ph.D. in Medicine from the University of New South Wales.

Investor type: Angel
Stages: Early Stage Venture
Invests in: Healthcare & BiotechBiotech & PharmaMedTech & Medical DevicesSaaS & EnterpriseIoT & Connected DevicesManufacturing & Industrial
Location: New South Wales
Typical check: $500K
Past investments: 2

Notable investments

Inteq LimitedClarity Pharmaceuticals

How to reach Alan Taylor

Angels and operators like Alan Taylor reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.

Frequently Asked Questions

What does Alan Taylor invest in?

Alan Taylor invests in Healthcare & Biotech, Biotech & Pharma, MedTech & Medical Devices and SaaS & Enterprise, typically at Early Stage Venture. Match your sector and stage, then reach out with a personalized pitch.